CS and malaria: To test the possibility of using MV-N-based RNPs as carrier to multimerize heterologous antigens in malaria vaccine prototypes, we fused the circumsporozoite (CS) antigen [49] from Pb (ANKA strain) to the C-terminus of MV-N through a linker of 7 amino acids (Figure 2A; Figure S1; [50]).